Jason offers more than 16 years of drug discovery and medicinal chemistry expertise to Kinnate. He joins Kinnate from Merck where he held positions of increasing responsibility, most recently as Director of Medicinal Chemistry, leading teams across all levels of preclinical discovery including target identification, target validation, lead identification and lead optimization. Jason has authored or co-authored 25 peer-reviewed journal articles and holds 22 patents spanning a diverse set of therapeutic areas. He holds a BA in biochemistry from Point Loma Nazarene University, a PhD in organic chemistry from the University of Arizona and was an American Cancer Society postdoctoral fellow at the University of Pennsylvania.
Current role